Replies to post #323817 on Innovation Pharmaceuticals Inc (IPIX)

[cybermich]

"The most time consuming steps any drug must go through involve human trials. Ab8 has to go through Phase 1 safety trial(s) before it can begin to think about Phase 2 human trials. And since none of the articles I’ve seen on Ab8 even talk about human trials, I think it fair to assume that they are nowhere near ready to start them. Brilacidin’s Phase 2 for Covid will be completed before Ab8 even begins a Phase 1."

Drop the mic.

[loanranger]

"And since none of the articles I’ve seen on Ab8 even talk about human trials, I think it fair to assume that they are nowhere near ready to start them."


(Pittsburgh) — University of Pittsburgh and UPMC researchers plan to start human trials early next year for an antibody therapy that might both prevent and treat COVID-19.
https://www.witf.org/2020/09/15/pitt-researchers-moving-forward-with-covid-19-antibody-therapy/

"What I guess everyone else wants to know is what is the clinical trial timeframe and how easily or expensively or or otherwise, is the A B eight manufactured? Thank you for that. A B eight should not be a greater expense to produce under CGMP conditions, and we are rapidly moving forward with that effort clinical trials require FDA approval, and the timeline, to be brief is the start of 2021. To manufacture do safety assessments in other animals to get FDA approval and to register and enroll clinical trials."
https://www.wtae.com/article/pitt-scientists-new-drug-discovery-covid-19-ab8/34017819#

[attilathehunt]

it should change name to sourpuss

[Lemoncat]

You can set up ”efficacy” as a strawman all you want but that changes nothing.

It's not a strawman, it was my entire statement. If you're disregarding efficacy, then Kevetrin, Humira, and Skittles are more advanced for COVID than Ab8 since they have shown safety in clinical trials. Discounting a more advanced efficacy test is foolish.

The most “advanced” drug will be the first to market and THAT is why Brilacidin is more “advanced” than Ab8.

We have no idea which will be first to market. If Ab8 gets picked up by a powerhouse BP, with all their lobbying power and FDA shortcuts, you might be surprised who makes it first.

I wouldn't even argue against the statement that "Brilacidin is more 'advanced' than Ab8" nor have I in any other post. It's my more specific statement about efficacy that you don't like. That's ok, that's what makes a market.

Brilacidin’s Phase 2 for Covid will be completed before Ab8 even begins a Phase 1.

Again, you're making factual statements about future events. We have no idea what development path Ab8 will take. We also have no idea what the results of Brilacidin will be against COVID in clinicals.

Go IPIX!